Tourbillon Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-248,603	Closed	-$10.8M	–	55
2017 Q1	$10.8M	Buy	+248,603	New	+$10.8M	0.28%	35
2015 Q4	–	Sell	-452,090	Closed	-$18M	–	51
2015 Q3	$18M	Buy	+452,090	New	+$18M	0.47%	33